Two Sigma Advisers’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,432
| Closed | -$61.1K | – | 2652 |
|
|
2023
Q1 | $61.1K | Sell |
8,432
-2,480
| -23% | -$18K | ﹤0.01% | 2431 |
|
|
2022
Q4 | $123K | Sell |
10,912
-5,484
| -33% | -$61.7K | ﹤0.01% | 2273 |
|
|
2022
Q3 | $216K | Buy |
16,396
+7,128
| +77% | +$93.9K | ﹤0.01% | 2177 |
|
|
2022
Q2 | $117K | Buy |
9,268
+2,816
| +44% | +$35.5K | ﹤0.01% | 2374 |
|
|
2022
Q1 | $371K | Buy |
6,452
+4,924
| +322% | +$283K | ﹤0.01% | 2133 |
|
|
2021
Q4 | $181K | Buy |
+1,528
| New | +$181K | ﹤0.01% | 2306 |
|
|
2021
Q2 | – | Sell |
-1,352
| Closed | -$268K | – | 2686 |
|
|
2021
Q1 | $268K | Sell |
1,352
-1,184
| -47% | -$235K | ﹤0.01% | 2263 |
|
|
2020
Q4 | $499K | Buy |
2,536
+248
| +11% | +$48.8K | ﹤0.01% | 1866 |
|
|
2020
Q3 | $406K | Buy |
2,288
+580
| +34% | +$103K | ﹤0.01% | 1899 |
|
|
2020
Q2 | $395K | Buy |
1,708
+384
| +29% | +$88.8K | ﹤0.01% | 1998 |
|
|
2020
Q1 | $154K | Buy |
1,324
+8
| +0.6% | +$931 | ﹤0.01% | 2230 |
|
|
2019
Q4 | $251K | Buy |
1,316
+680
| +107% | +$130K | ﹤0.01% | 2115 |
|
|
2019
Q3 | $122K | Buy |
636
+84
| +15% | +$16.1K | ﹤0.01% | 2096 |
|
|
2019
Q2 | $95K | Buy |
+552
| New | +$95K | ﹤0.01% | 2217 |
|